Category: Business News
CHICAGO – December 16, 2021 – EVERSANA, the pioneer of next generation services to the global life sciences industry, today announced an agreement with Janssen Research & Development, LLC (Janssen) to transform clinical data into the much-needed evolution of chronic disease care through real-word data (RWD), data science analysis and regulatory-grade studies. The collaboration between EVERSANA’s RWD Solution team and the Janssen Research & Development Data Science team will help drive evidence-based development of Janssen therapies, treatments and patient support models.
Traditionally, real-world evidence regarding chronic disease care —including treatment patterns and outcomes—is limited. The patient experience, ranging from pain, fatigue, mental health and socio/behavioral impact, is not analyzed in traditional RWD studies.